Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies

Joshi, Shrinidh A., Chavhan, Sandip S., Sawant, Krutika K.·2010·European Journal of Pharmaceutics and Biopharmaceutics

Cited by (234)

Items 101–200 of 234

  1. Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
    Elisa Garbayo, Ander Estella‐Hermoso de Mendoza, María J. Blanco‐Prieto · 2014 · Current Medicinal Chemistry
  2. In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach.
    P. Sathler, A. Lourenço, C. Rodrigues, L. C. R. Pereira da Silva, L. Cabral, A. K. Jordão, A. Cunha, M. Vieira, V. Ferreira, C. Carvalho-Pinto et al. · 2014 · Thrombosis Research
  3. Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability
    Pankaj Vijay Dangre, Ritu Mehra Gilhotra, Shashikant Nivrutti Dhole · 2016 · Drug Delivery and Translational Research
  4. The application of multifunctional nanomaterials in Alzheimer’s disease: A potential theranostics strategy
    Yilan Xu, Man-Na Zhao, Dongming Zhou, Tingting Zheng, Heng Zhang · 2021 · Biomedicine & Pharmacotherapy
  5. An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect
    Mohamed Hamdi, Hend Mohamed Abdel‐Bar, Enas M. Elmowafy, Khuloud T. Al‐Jamal, Gehanne A.S. Awad · 2020 · PLoS ONE
  6. Current Progresses on Nanodelivery Systems for the Treatment of Neuropsychiatric Diseases: Alzheimer’s and Schizophrenia
    Ana Catarina Silva, Elisabet González‐Mira, José Manuel Sousa Lobo, Maria Helena Amaral · 2013 · Current Pharmaceutical Design
  7. Cholesterol–PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations
    Xiao Hu, Feifei Yang, Yonghong Liao, Li Lin, Lan Zhang · 2017 · Drug Delivery
  8. Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease
    Gifty M. Jojo, Gowthamarajan Kuppusamy · 2019 · Journal of Clinical Pharmacy and Therapeutics
  9. Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis
    Mohammad Fazil, Md Quamrul Hassan, Sanjula Baboota, Javed Ali · 2015 · Drug Delivery
  10. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease
    Sara Hernando, Edorta Santos‐Vizcaíno, Manoli Igartúa, Rosa Marı́a Hernández · 2023 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  11. Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches
    Shakeel Ahmed Ansari, Rukhsana Satar, Asma Perveen, Ghulam Md Ashraf · 2016 · Current Opinion in Psychiatry
  12. Optimization of sustained release aceclofenac microspheres using response surface methodology
    Rameshwar K. Deshmukh, Jitendra Naik · 2014 · Materials Science and Engineering C
  13. Plantago ovata F. Mucilage-Alginate Mucoadhesive Beads for Controlled Release of Glibenclamide: Development, Optimization, and In Vitro-In Vivo Evaluation
    Amit Kumar Nayak, Dilipkumar Pal, Kousik Santra · 2013 · Journal of Pharmaceutics
  14. Enhancement of Oral Bioavailability of Puerarin by Polybutylcyanoacrylate Nanoparticles
    Li-Xia Zhao, Anchang Liu, Min Ho Sun, Jinsong Gu, Haigang Wang, Shuang Wang, Jing Zhang, Chenyu Guo, Rui Duan, Guangxi Zhai · 2011 · Journal of Nanomaterials
  15. An Alternative Approach for Improved Entrapment Efficiency of Hydrophilic Drug Substance in PLGA Nanoparticles by Interfacial Polymer Deposition Following Solvent Displacement
    Sara Salatin, Jaleh Barar, Mohammad Barzegar-Jalali, Khosro Adibkia, Farhad Kiafar, Mitra Jelvehgari · 2018 · Jundishapur Journal of Natural Pharmaceutical Products
  16. Promising Therapies for Alzheimer';s Disease
    Annamaria Confaloni, Giuseppe Tosto, Ada Maria Tata · 2016 · Current Pharmaceutical Design
  17. Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer’s disease
    Faisal Imam, Sayantan Mukhopadhyay, Preeti Kothiyal, Samiyah Alshehri, Khalid Saad Alharbi, Muhammad Afzal, Muzaffar Iqbal, Mohammad Rashid Khan, Md. Khalid Anwer, Abdulrazaq Ahmed Hattab Alanazi et al. · 2024 · Saudi Pharmaceutical Journal
  18. Formulation and statistical optimization of gastric floating alginate/oil/chitosan capsules loading procyanidins: in vitro and in vivo evaluations
    Rencai Chen, Xiaomin Guo, Xuecong Liu, Haiming Cui, Rui Wang, Jing Han · 2017 · International Journal of Biological Macromolecules
  19. Development of Blood-Brain Barrier Permeable Nanoparticles as Potential Carriers for Salvianolic Acid B to CNS
    Cristina Grossi, Clizia Guccione, Benedetta Isacchi, Maria Camilla Bergonzi, Ilaria Luccarini, Fiorella Casamenti, Anna Rita Bilia · 2016 · Planta Medica
  20. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine
    Priti Girotra, Shailendra Kumar Singh · 2016 · Pharmaceutical Research
  21. Therapeutic Compliance of Nanomedicine in Alzheimer’s Disease
    Barnabas Wilson · 2011 · Nanomedicine
  22. Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles
    Vanesa Nozal, Elisa Rojas‐Prats, Inés Maestro, Carmen Gil, Daniel I. Pérez, Ana Martı́nez · 2021 · International Journal of Molecular Sciences
  23. Nanobiotechnology in Neurodegenerative Diseases
    Josef Jampílek, Katarína Kráľová, Petr Novák, Michal Novák · 2019 · Springer eBooks
  24. Nanopharmaceuticals: Innovative theranostics for the neurological disorders
    Parichehr Hassanzadeh · 2014 · Biomedical Reviews
  25. Application of multiple regression analysis in optimization of anastrozole-loaded PLGA nanoparticles
    Abhinesh Kumar, Krutika Khanderao Sawant · 2013 · Journal of Microencapsulation
  26. Nanotechnology-based approaches for tuberculosis treatment
    Mohamad Mosa Mubarak, Zahoor Ahmad · 2020 · Elsevier eBooks
  27. Drug Delivery Systems and Strategies to Overcome the Barriers of Brain
    Yogesh Garg, Deepak N. Kapoor, Abhishek Kumar Sharma, Amit Bhatia · 2021 · Current Pharmaceutical Design
  28. Emulsion-core and polyelectrolyte-shell nanocapsules: biocompatibility and neuroprotection against SH-SY5Y cells
    Marek Piotrowski, Krzysztof Szczepanowicz, Danuta Jantas, Monika Leśkiewicz, Władysław Lasoń, Piotr Warszyński · 2013 · Journal of Nanoparticle Research
  29. Fluorinated Molecules and Nanotechnology: Future ‘Avengers’ against the Alzheimer’s Disease?
    Meghna Dabur, Joana A. Loureiro, Maria do Carmo Pereira · 2020 · International Journal of Molecular Sciences
  30. Gastrointestinal Responsive Polymeric Nanoparticles for Oral Delivery of Insulin: Optimized Preparation, Characterization, and In Vivo Evaluation
    Yan Fang, Qi Wang, Xiaojie Lin, Xuechao Jin, Dongjuan Yang, Shan Gao, Xiyan Wang, Mingshi Yang, Kai Shi · 2019 · Journal of Pharmaceutical Sciences
  31. Lipid-core nanocapsules containing simvastatin improve the cognitive impairment induced by obesity and hypercholesterolemia in adult rats
    Ricardo Lorenzoni, Samuel Davies, Leticia Malgarim Cordenonsi, José Alcides da Silva Viçosa, Nathana J. Mezzomo, Amanda Lima de Oliveira, Guilherme Machado do Carmo, Renata Platcheck Raffin, Oswaldo Luiz Alves, Rodrigo de Almeida Vaucher et al. · 2020 · European Journal of Pharmaceutical Sciences
  32. Nanomedicine against Alzheimer’s and Parkinson’s Disease
    Ankit Tandon, Sangh Jyoti Singh, Rajnish Kumar Chaturvedi · 2020 · Current Pharmaceutical Design
  33. The Role of Nanoparticle in Brain Permeability: An in-vitro BBB Model.
    Niusha Nikandish, Leila Hosseinzadeh, Abbas Hemati Azandaryani, Katayoun Derakhshandeh · 2016 · PubMed Central
  34. Optimization and characterization of sertaconazole nitrate flexisomes embedded in hydrogel for improved antifungal activity
    Satish K. Mandlik, Shridhar S. Siras, Kiran R. Birajdar · 2017 · Journal of Liposome Research
  35. Rivastigmine hydrogen tartrate polymorphs: Solid-state characterisation of transition and polymorphic conversion via milling
    Maria Inês Amaro, Alice Simon, Lúcio Mendes Cabral, Valéria Pereira de Sousa, Anne Marie Healy · 2015 · Solid State Sciences
  36. A Multioptimization Approach to Assessment of Drug Delivery of PLGA Nanoparticles: Simultaneous Control of Particle Size and Release Behavior
    Bahareh Baghaei, Seyed Hassan Jafari, Hossein Ali Khonakdar, Mohammad Reza Saeb, Udo Wagenknecht, Gert Heinrich · 2015 · International Journal of Polymeric Materials
  37. Fabrication of chitosan/collagen/hydroxyapatite scaffolds with encapsulated Cissus quadrangularis extract
    Nareerat Thongtham, Poowadon Chai‐in, Onuma Unger, Suwimon Boonrungsiman, Orawan Suwantong · 2020 · Polymers for Advanced Technologies
  38. Nanoformulated cell-penetrating survivin mutant and its dual actions
    Jagat R. Kanwar, Bhasker Sriramoju, Rupinder K Kanwar · 2014 · International Journal of Nanomedicine
  39. Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin–Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity
    Ying Xu, Lei Tang, Peng Chen, Mei Chen, Miaomiao Zheng, Feng Shi, Yanchun Wang · 2021 · AAPS PharmSciTech
  40. Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases
    Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova, Jianqin Lu · 2023 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  41. Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery
    Mithun Rudrapal · 2022 · IntechOpen eBooks
  42. Amyloid –β pathology in Alzheimer’s disease: A nano delivery approach
    G. S. Meghana, DV Gowda, Saravana Babu Chidambaram, Riyaz Ali M. Osmani · 2023 · Vibrational Spectroscopy
  43. Nanofiber power: Reinforcing in-situ hydrogel for enhanced rivastigmine delivery
    Khushwant S. Yadav, Harsh P. Nijhawan, Prachi Gite, Saritha Rakesh Shetty · 2024 · Journal of Drug Delivery Science and Technology
  44. Interaction of gentamicin and gentamicin-AOT with poly-(lactide-co-glycolate) in a drug delivery system - density functional theory calculations and molecular dynamics simulation
    Shahid Duran, Jamshed Anwar, Syed Tarique Moin · 2023 · Biophysical Chemistry
  45. Alzheimer's Disease: Status of Low‐Dimensional Nanotherapeutic Materials
    Dongqing Huang, Wang Liao, Jun Li, Tongkai Chen, Xinlu Wang, Ruiyue Zhao, Lingyan Zhang, Xue‐Feng Yu, Dong Zheng, Ping Luan · 2023 · Advanced Functional Materials
  46. Alzheimer hastalığı tedavisinde nano boyutlu ilaç taşıyıcı sistemlerin kullanımı
    DERELİ Nadir GÜN · 2016 · Ankara Universitesi Eczacilik Fakultesi Dergisi
  47. An optimistic approach to nanotechnology in Alzheimer's disease management: An overview
    Varsha Tiwari, Abhishek Tiwari, Ajay Sharma, Manish Kumar, Deepak Kumar Kaushik, Suresh Sagadevan · 2023 · Journal of Drug Delivery Science and Technology
  48. In Vitro Release Test of Nano-drug Delivery Systems Based on Analytical and Technological Perspectives
    Emirhan Nemutlu, İpek Eroğlu, Hakan Eroğlu, Sedef Kır · 2018 · Current Analytical Chemistry
  49. Nanomedicine-Driven Therapeutic Interventions of Autophagy and Stem Cells in The Management of Alzheimer’s Disease
    Fahad Saad Alhodieb, Mohammad Akhlaquer Rahman, Muhammad Abul Barkat, Abdulkareem Ali Alanezi, Harshita Abul Barkat, Hazrina Ab. Hadi, Ranjit Kumar Harwansh, Vineet Mittal · 2023 · Nanomedicine
  50. SYNTHESIS AND CHARACTERIZATION OF POLY D-L LACTIDE (PLA) NANOPARTICLES FOR THE DELIVERY OF QUERCETIN
    Bharathi Sambandam, S. Sathesh Kumar, Ayyaswamy Arivarasan, Nagarjuna Yadav B, Devasena Thiyagarajan · 2015 · International Journal of Pharmacy and Pharmaceutical Sciences
  51. Inducing Agents for Alzheimer’s Disease in Animal Models
    Karishma Khan, Nasr Ali Emad, Yasmin Sultana · 2024 · Journal of Exploratory Research in Pharmacology
  52. Development and Optimization of w/o/w Multiple Emulsion of Lisinopril Dihydrate Using Plackett Burman and Box-Behnken Designs
    KK Sawant, Veenu P. Mundada, Patel VJ · 2017 · Journal of Nanomedicine & Nanotechnology
  53. POSSIBLE THERAPEUTIC ROLE OF JASONIA CANDICANS AND JASONIA MONTANA EXTRACTS IN THE REGRESSION OF ALZHEIMER’S DISEASE IN EXPERIMENTAL MODEL
    Hanaa Hamdy Ahmed · 2013 · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology
  54. n-Butyl Cyanoacrylate Synthesis. A New Quality Step Using Microwaves
    Yaquelin Ramos Carriles, Rubén Álvarez Brito, Ricardo Martínez Sánchez, E. Acevedo, Paola Domínguez, Wolf‐Dieter Müeller · 2014 · Molecules
  55. Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease
    Sophia G. Antimisiaris, Spyridon Mourtas, Eleni Markoutsa, Αθανάσιος Σκούρας, Κωνσταντίνα Παπαδιά · 2014 · Advanced Healthcare Materials
  56. Oral Dissolving Film of Rivastigmine: Optimization Using Factorial Design
    Dalia Ali Farghaly, Samar A. Afifi, Ahmed A. Aboelwafa, Magdy Ibrahim Mohamed · 2023 · Journal of Pharmaceutical Innovation
  57. In situ encapsulation of rivastigmine in TAT-functionalized P(MMA-co-AA) nanoparticles through miniemulsion polymerization
    Lys H. R. Mangia, Helen Conceição Ferraz, Raquel Santos de Souza, Mirian Cláudia de Souza Pereira, José Carlos Pinto · 2021 · Colloids and Surfaces A Physicochemical and Engineering Aspects
  58. Enhancement of Bioavailability Through Transdermal Drug Delivery of Paliperidone Palmitate-Loaded Nanostructured Lipid Carriers
    Shilpa Raval, Parva Jani, Pravin Patil, Parth Thakkar, Krutika Khanderao Sawant · 2021 · Therapeutic Delivery
  59. Preparation, optimization by 23 factorial design, characterization and in vitro release kinetics of lorazepam loaded PLGA nanoparticles
    Sarvesh Bohrey, Vibha Chourasiya, Archna Pandey · 2016 · Polymer Science Series A
  60. Formulation of acyclovir-loaded solid lipid nanoparticles: 2. Brain targeting and pharmacokinetic study
    Sanaa A. El‐Gizawy, Gamal Mohamed El Maghraby, Asmaa A. Hedaya · 2019 · Pharmaceutical Development and Technology
  61. Advancing anticorrosion and antibacterial performance of mg AZ31 implants using novel pH-responsive polymeric surfactant for preparing PLGA nanoparticles
    Hanie Ahmadi, Vahid Haddadi‐Asl, Hossein Eivaz Mohammadloo · 2024 · Surface and Coatings Technology
  62. Poly(butyl cyanoacrylate) nanoparticle containing an organic photoCORM
    Adnan Elgattar, Kenyatta S. Washington, Somayeh Talebzadeh, Almutasim A. Alwagdani, Thaaer Khalil, Osamah Alghazwat, Sultan Alshammri, Hemant Pal, Chris A. Bashur, Yi Liao · 2019 · Photochemical & Photobiological Sciences
  63. Development of Alginate- Neusilin US2 (Magnesium alumino-metasilicate) micro-composite hydrogel beads for oral sustained release of cilnidipine: a statistical optimization
    Pankaj Vijay Dangre, Swapnil Dudhkohar, Shailesh S. Chalikwar · 2019 · Polymer-Plastics Technology and Materials
  64. Intramuscularly Administered PLGA Microparticles for Sustained Release of Rivastigmine: In Vitro, In Vivo and Histological Evaluation
    Javier Avendaño-Godoy, Arnoldo Miranda, Sigrid Mennickent C, Carolina Gómez-Gaete · 2023 · Journal of Pharmaceutical Sciences
  65. DRUMSTICK MUCILAGE MICROSPHERES FOR CONTROLLED RELEASE OF LAMIVUDINE: DESIGN, OPTIMIZATION AND IN VITRO EVALUATION
    Santosh Gada, Y. ANANDKUMAR, C. Mallikarjuna Setty · 2019 · International Journal of Pharmacy and Pharmaceutical Sciences
  66. Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease
    Niloufar Choubdar, Sara Avizheh · 2019 · Nanoscience &amp Nanotechnology-Asia
  67. Poly(DL-lactide-co-glycolic acid) Nanoparticle Design and Payload Prediction: A Molecular Descriptor Based Study
    Suvadra Das, Partha Roy, Md Ataul Islam, Achintya Saha, Arup Mukherjee · 2012 · Chemical and Pharmaceutical Bulletin
  68. Principle characteristics and specification of pharmaceutical polymers
    Pankaj Sharma, Bindu Rathore, Saloni Jain, Mahendra Pal Sharma, Satendra Tiwari, Ramu Kaushal, Wasim Akram, Vinay Jain · 2024 · Elsevier eBooks
  69. Biobased Nanomaterials in Drug Delivery
    Melike Erduran, Nevin Çankaya, Serap Yalçın · 2024 · Springer eBooks
  70. Optimized scleroglucan production by Athelia rolfsii and in vitro Sclg-5-fluorouracil release investigations
    Azza M. Noor El-Deen, Islam A. Elsehemy, Eman H. Ahmed, Hassan Mohamed Awad, Mohamed Abdel Fattah Farid · 2024 · International Journal of Biological Macromolecules
  71. An In vivo Investigation of Ascorbic Acid Tethered Polymeric Nanoparticles for Effectual Brain Transport of Rivastigmine
    Kavita Rai Gajbhiye, Vandana Soni · 2022 · Current Drug Delivery
  72. Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review
    Sara Silva, António José Almeida, Nuno Vale · 2021 · Journal of Nanoparticle Research
  73. Fabrication of carotenoid enriched Crocus sativus w/o nanoemulsion: Optimization and pharmaceutical characterization
    Namrata Aashish Parikh, Komal Patel, Abhay T. Dharamsi · 2024 · Journal of Applied Pharmaceutical Science
  74. Nanoparticle-mediated delivery of AChE inhibitors for the treatment of Alzheimer’s disease
    Pallav Namdeo, Jinu Mathew, Ashish Garg · 2022 · Elsevier eBooks
  75. Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients
    Sankha Bhattacharya · 2022 · Current Pharmaceutical Biotechnology
  76. Preparation and Optimization of Dry PLGA Nanoparticles by Spray Drying Technique
    Deepak Sunil Bhambere, Birendra Shirivastava, Pankaj Kumar Sharma, Nisha Bukane, Paraag Gide · 2013 · Particulate Science And Technology
  77. PLGA mediated drug delivery for Alzheimer's disease
    Tosha Pandya, Mangesh Kulkarni, Sheetal Porecha Acharya, Bhupendra Gopalbhai Prajapati · 2024 · Elsevier eBooks
  78. FORMULATION OF POLYMERIC NANOSUSPENSION CONTAINING PRAMIPEXOLE DIHYDROCHLORIDE AND HESPERIDIN FOR IMPROVED TREATMENT OF PARKINSON’S DISEASES
    I. Somasundaram · 2018 · Asian Journal of Pharmaceutical and Clinical Research
  79. PREPARATION AND CHARACTERIZATION OF GEMCITABINE LOADED MPEG-PCL POLYMERIC NANOPARTICLES FOR IMPROVED TRANSPORTATION ACROSS BLOOD BRAIN BARRIER
    Bhuneshwar Yadav, V. Ravichandiran, S. Sathesh Kumar · 2015 · International Journal of Pharmacy and Pharmaceutical Sciences
  80. Nanomedicine for Treating Major Brain Diseases: Advances and Future Directions
    Girisha Sagar, Barnabas Wilson, Geetha Kannoth Mukundan, Kalpana Divekar, J. Josephine Leno Jenita⃰ · 2025 · Molecular Pharmaceutics
  81. Nanodelivery systems for Alzheimer's disease: Prospects of natural therapeutic agents
    Oluwatoyin A. Odeku, Tolulope O. Ajala · 2021 · Journal of Applied Pharmaceutical Science
  82. Recent Advancements in Phyto Component Based Nanocarriers for Improved Treatment of Brain Disorders
    Bhabani Sankar Satapathy, Snigdha Pattnaik, Sangram Keshari Biswal, Biswabhusan Biswal, Pralaya Kumar Sahoo, Himansu Bhusan Samal, Binapani Barik · 2023 · IntechOpen eBooks
  83. Permeability and in vivo distribution of poly(Ɛ-caprolactone) nanoparticles loaded with zidovudine
    Milena Cristina Ribeiro Souza Magalhães, Brenda Fernanda Moreira Castro, Whocely Victor de Castro, André Luís Branco de Barros, Renata Salgado Fernandes, Armando Silva‐Cunha, Sílvia Ligório Fialho · 2018 · Journal of Nanoparticle Research
  84. Quality-by-design Enabled Chitosan Nanoparticles for Antitubercular Therapy: Formulation, Statistical Optimization, and In Vitro Characterization
    Manasi M. Chogale, Sujay S. Gaikwad, Savita P Kulkarni, Vandana Bharat Patravale · 2020 · Current Drug Therapy
  85. Drug delivery and functional nanoparticles
    Dipayan Roy, Anupama Modi, Ritwik Ghosh, Julián Benito‐León · 2023 · Elsevier eBooks
  86. Physicochemical Requirements for Polymers and Polymer-Based Nanomaterial for Ophthalmic Drug Delivery
    Sheeba Varghese Gupta · 2016 · Springer eBooks
  87. Nanotechnology Based Approaches for Neurodegenerative Disorders: Diagnosis and Treatment
    Sara Hernando, Enara Herrán, José Luís Pedraz, Manoli Igartúa, Rosa Marı́a Hernández · 2017 · Springer eBooks
  88. Nanoparticle-based drug delivery for Alzheimer's disease
    Barnabas Wilson · 2015
  89. Polymeric nanoparticles as drug delivery systems for dementia
    Gerard Esteruelas, Eliana B. Souto, Amanda C. Cano, Miren Ettcheto, Marta Espina, Antoni Camins, Maria Luisa García, Elena Sánchez‐López · 2022 · Elsevier eBooks
  90. Challenges of Using Nanotechnology for Neurological Disorders and Alternate Solutions
    Swarnali Das, Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, Sandeep Kumar Dash · 2023 · Springer eBooks
  91. OPTIMIZATION AND CHARACTERIZATION OF RIVASTIGMINE-LOADED NANOSTRUCTURED LIPID CARRIERS
    Swathi Ganna, Sai Manogna Kotakadi, Reshma Anjum Mohammed, Mannur Ismail Shaik, John Sushma Nannepaga · 2021 · International Journal of Current Pharmaceutical Research
  92. Development and in vitro evaluation of Strawberry fruit extract loaded biodegradable nanoparticles in therapy for neurodegenerative disorders
    Jayshree Nellore, Kanchana Amarnath · 2011 · International Conference on Nanoscience, Engineering and Technology (ICONSET)
  93. Recent Advances in the Development of Parenteral Dosage Forms
    Abdul Muheem, Sobiya Zafar, Mohammed Asadullah Jahangir, Musarrat Husain Warsi, Syed Sarim Imam, Gaurav Kumar Jain, Farhan Jalees Ahmad · 2020 · Apple Academic Press eBooks
  94. Formulation and Optimization of Rivastigmine-Loaded PLGA and Chitosan Nanoparticles for Transdermal Delivery
    Sneh Priya, Poornima Poornima, Cynthia Lizzie Lobo · 2023 · Research Journal of Pharmacy and Technology
  95. Nanopolymers and Nanoconjugates for Central Nervous System Diagnostics and Therapies
    Giancarlo Suffredini, Lucien Levy C · 2013 · CRC Press eBooks
  96. Improving Treatment of Stroke through Nanotechnology
    Francesca J. Nicholls, Natalia Gorenkova, Ellen Bible, Christy Lynn Franco, David Y. S. Chau, Christos Michael Tolias, Kevin M. Shakesheff, Jennifer West, Michel Modo · 2013 · CRC Press eBooks
  97. Physicochemical properties of nanosized polymeric drug carrier systems
    Nicoletta Rescignano, Josè Maria Kenny · 2018 · Elsevier eBooks
  98. Fe3O4@SiO2@CeO2 as a Potential Nanomagnetic Carrier for Oral Delivery System and Release of Celecoxib
    Maryam Kargar, Shabnam Ahmadvand, Babak Sadeghi, Seyedeh Sara Mirfazli · 2021 · Combinatorial Chemistry & High Throughput Screening
  99. ENHANCEMENT OF SKIN PERMEABILITY OF ECONAZOLE NITRATE USING NOVEL FLEXISOMAL NANOCARRIERS BY IMPLEMENTING QUALITY BY DESIGN (QBD) APPROACH
    Satish K. Mandlik, HARSHAL P. DANDGAVHAL · 2019 · International Journal of Applied Pharmaceutics
  100. Applications of Nanotechnology in Alzheimer’s Disease
    Maria Chountoulesi, Nikolaos Naziris, Anna Gioran, Aristeidis Papagiannopoulos, Barry R. Steele, Maria Micha‐Screttas, Stavros G. Stavrinides, Michael P. Hanias, Niki Chondrogianni, Stergios Pispas et al. · 2023 · Springer eBooks